Amoebiasis, caused by the intestinal protozoan parasite Entamoeba histolytica, remains an important public health concern in regions where inadequate sanitation, unsafe water supplies, and poor food hygiene facilitate fecal–oral transmission. The infection ranges from asymptomatic intestinal colonization to invasive colitis and potentially life-threatening extraintestinal complications, particularly amoebic liver abscess. In Iraq, the epidemiological distribution of intestinal parasitic infections is influenced by differences in environmental conditions, sanitation infrastructure, access to healthcare, and the availability of reliable diagnostic services. However, reported prevalence estimates must be interpreted carefully because many hospital-based studies investigate intestinal parasites collectively or rely on conventional microscopy, which cannot reliably distinguish E. histolytica from morphologically similar non-invasive species. This review examines the epidemiological determinants, transmission pathways, biological characteristics, pathogenic mechanisms, clinical manifestations, and diagnostic approaches associated with amoebiasis, with particular emphasis on their relevance to medical education and public health practice in Iraq. It also discusses evidence-based therapeutic principles and preventive strategies, highlighting the importance of species-specific laboratory diagnosis, appropriate treatment, environmental sanitation, and improved epidemiological surveillance. Strengthening these measures is essential for obtaining more reliable estimates of the disease burden and improving the prevention and management of amoebiasis in Iraqi communities. Keywords: Entamoeba histolytica; amoebiasis; epidemiology; amoebic colitis; amoebic liver abscess; molecular diagnosis; Iraq; public health. Introduction Amoebiasis is a parasitic infection caused by Entamoeba histolytica, an intestinal protozoan capable of invading the colonic mucosa and producing disease ranging from asymptomatic infection to severe intestinal inflammation and extraintestinal complications. The parasite remains clinically important because its transmission is closely associated with environmental sanitation, water quality, food hygiene, and socioeconomic conditions. Although many infected individuals do not develop symptoms, some progress to invasive intestinal disease, which may present with abdominal pain, diarrhoea, and dysentery. In a smaller proportion of patients, the parasite spreads beyond the intestine and causes extraintestinal disease, most commonly an amoebic liver abscess. These different clinical outcomes make amoebiasis an important subject in medical parasitology, infectious disease diagnosis, and public health. The clinical and epidemiological significance of E. histolytica depends on the interaction between the parasite, the human host, and the surrounding environment. The ingestion of infective cysts through contaminated water, food, or hands represents the principal route of transmission. Consequently, communities experiencing inadequate wastewater treatment, intermittent access to safe drinking water, overcrowding, or limited sanitation facilities may face an increased risk of infection. Nevertheless, the presence of intestinal parasitic infections in a population does not necessarily indicate that all cases are caused by E. histolytica. Accurate epidemiological assessment requires species-specific identification because several intestinal amoebae share similar morphological characteristics but differ substantially in their pathogenic potential. In Iraq, the burden of intestinal parasitic infections should therefore be evaluated in the context of regional environmental conditions, population characteristics, sanitation infrastructure, and the diagnostic methods used in individual studies. Research conducted in hospitals, outpatient clinics, and selected communities may provide valuable information about local patterns of infection; however, the results of these investigations cannot automatically be generalized to the entire population. Hospital-based studies are particularly susceptible to selection bias because the participants are individuals who seek medical attention rather than a representative sample of all residents. In addition, differences in specimen collection, laboratory techniques, age distribution, and study design may explain some of the variation between reported prevalence estimates. A reliable understanding of amoebiasis in Iraq consequently requires careful interpretation of published findings and the development of standardized surveillance methods that distinguish confirmed E. histolytica infection from other intestinal parasitic conditions. Epidemiology, Transmission, and Environmental Determinants The epidemiology of amoebiasis is closely related to the fecal–oral transmission cycle of E. histolytica. Infection occurs primarily when a person ingests mature, infective cysts present in contaminated drinking water, uncooked food, or contaminated hands. After ingestion, the cysts survive passage through the stomach and undergo excystation in the small intestine, releasing trophozoites that subsequently colonize the large intestine. Infected individuals may pass cysts in their faeces, allowing the parasite to persist in the environment and reach new human hosts when sanitation and hygiene measures are inadequate. Cysts are relatively resistant to environmental conditions compared with trophozoites, which are more fragile outside the human body. This difference explains why cysts, rather than trophozoites, represent the principal infective stage in ordinary fecal–oral transmission. The transmission of E. histolytica is facilitated by deficiencies in drinking-water treatment, inadequate sewage disposal, contamination of food during preparation, and insufficient hand hygiene. Mechanical transfer by flies and cockroaches may contribute under certain environmental conditions, although these insects are not the principal biological route of transmission. Direct person-to-person transmission can also occur, particularly when infected faecal material contaminates hands or surfaces. Sexual practices involving exposure to faecal material represent another recognized transmission pathway in some populations. Therefore, effective prevention requires an integrated approach addressing water safety, food hygiene, sanitation, personal hygiene, and appropriate diagnosis and treatment of infected individuals. Within Iraq, the distribution of amoebiasis should be interpreted against the background of regional differences in water availability, sewage management, population density, climate, and access to laboratory services. Variations between governorates such as Baghdad, Basra, Dhi Qar, Nineveh, Dohuk, Maysan, Najaf, Anbar, and Babil may reflect differences in environmental exposure, the populations investigated, and the sensitivity of the diagnostic techniques employed. However, a higher percentage of intestinal parasitic infections reported in a particular hospital does not necessarily demonstrate a higher prevalence of E. histolytica among the general population of that governorate. The denominator is particularly important: the proportion of positive results among patients referred for stool examination is not equivalent to population prevalence, and the proportion of all intestinal parasites represented by amoebae is not equivalent to the prevalence of confirmed amoebiasis. A further epidemiological limitation concerns the distinction between E. histolytica and morphologically similar species, particularly Entamoeba dispar and Entamoeba moshkovskii. These organisms may be difficult or impossible to differentiate reliably by routine light microscopy. Consequently, prevalence estimates based exclusively on microscopic identification of cysts or trophozoites may overestimate the actual burden of pathogenic E. histolytica infection. Molecular methods and species-specific antigen detection can improve the accuracy of epidemiological investigations, although their availability and performance depend on laboratory infrastructure, specimen quality, and the specific assay used. Future Iraqi studies would benefit from standardized diagnostic definitions, representative sampling, clearly reported age groups, and confirmation of suspected E. histolytica infection using validated species-specific methods. Children may be particularly vulnerable to intestinal parasitic infections because of behavioural exposure, developing hygiene practices, and frequent contact with contaminated environments. However, the risk of acquiring infection should be distinguished from the risk of developing severe invasive disease, which also depends on host immunity, parasite characteristics, and other individual factors. Malnutrition and intestinal infections may coexist and contribute to poor health outcomes, but an observed association does not establish that amoebiasis alone caused anaemia, nutritional deficiency, or impaired growth. These outcomes require appropriate clinical and laboratory assessment, especially in populations where several infectious and nutritional conditions may occur simultaneously. Biological Characteristics and Pathogenesis Entamoeba histolytica exists principally in two morphological forms during its human infection cycle: the cyst and the trophozoite. The mature cyst is the environmentally resistant, infective stage and typically contains four nuclei. Its protective wall enables it to survive passage through the gastrointestinal tract and facilitates transmission between hosts. Following ingestion, excystation releases amoebic forms that develop into trophozoites and establish themselves in the large intestine. Trophozoites are the active feeding and multiplying forms and may remain within the intestinal lumen without producing clinical symptoms. Alternatively, they may interact with the intestinal epithelium, damage the mucosal barrier, and invade underlying tissues, resulting in symptomatic disease. The ability of E. histolytica to cause invasive disease depends on several interacting virulence mechanisms. Adhesion to host cells is mediated partly by a galactose- and N-acetyl-D-galactosamine-inhibitable lectin, commonly referred to as the Gal/GalNAc lectin. This molecule supports attachment to intestinal epithelial cells and contributes to resistance against host defence mechanisms. The parasite also produces cysteine proteases and other factors that damage host tissues, disrupt extracellular structures, and interfere with immune responses. In addition, amoebic trophozoites can induce host-cell death through contact-dependent mechanisms and phagocytose cellular material. Together, these processes contribute to epithelial injury, inflammation, and tissue destruction. When trophozoites invade the colonic mucosa, they may produce characteristic flask-shaped ulcers. These lesions have relatively narrow openings at the mucosal surface and extend laterally into the underlying tissues, although their appearance varies according to the extent and duration of infection. Mucosal damage may lead to bleeding, mucus production, abdominal discomfort, and inflammatory diarrhoea. In severe cases, extensive colitis may cause substantial fluid loss, intestinal bleeding, or, rarely, complications such as toxic megacolon and intestinal perforation. These severe manifestations require urgent clinical assessment because they may be associated with significant morbidity and mortality. The clinical outcome of infection is not determined by parasite virulence alone. Host immune responses, intestinal microbiota, nutritional status, genetic susceptibility, and other environmental or physiological factors may influence whether infection remains asymptomatic or progresses to invasive disease. Although intestinal colonization can persist without obvious symptoms, the presence of an amoeba detected microscopically does not automatically establish invasive amoebiasis. Correct species identification and clinical interpretation are therefore essential for determining the significance of a positive laboratory result. Extraintestinal spread occurs when invasive trophozoites cross the intestinal mucosa and enter the portal circulation. The liver is the most frequently affected extraintestinal organ because portal venous blood drains the intestine into the hepatic circulation. Within the liver, the parasite and the associated inflammatory response produce tissue destruction and the formation of an amoebic liver abscess. The right hepatic lobe is commonly involved, although lesions may occur elsewhere. In uncommon cases, disease may extend to the pleural cavity or lungs, and cerebral involvement may occur rarely. These complications illustrate why early recognition of invasive amoebiasis is important, particularly in patients presenting with compatible gastrointestinal symptoms or unexplained fever and hepatic pain. Clinical Manifestations and Complications The clinical spectrum of amoebiasis ranges from asymptomatic intestinal infection to severe intestinal and extraintestinal disease. Many infected individuals remain asymptomatic, and the proportion varies across populations, study designs, and diagnostic methods. Asymptomatic infection is epidemiologically important because infected individuals may shed cysts and contribute to transmission. However, the duration and intensity of cyst shedding are variable, and not every person with a positive stool examination necessarily represents a major source of community transmission. Clinical evaluation must also distinguish asymptomatic infection with confirmed E. histolytica from the incidental detection of non-pathogenic intestinal amoebae. Symptomatic intestinal amoebiasis may develop gradually or present with acute gastrointestinal symptoms. Common manifestations include abdominal pain, cramping, diarrhoea, and altered bowel habits. In invasive amoebic colitis, stools may contain blood and mucus, producing a dysenteric syndrome. Patients may also experience urgency, tenesmus, fatigue, reduced appetite, and weight loss. Fever can occur, particularly in more severe disease, but its absence does not exclude amoebic colitis. The clinical presentation is not specific, and bacterial enteric infections, inflammatory bowel disease, and other causes of infectious colitis may produce similar symptoms. Consequently, a clinical diagnosis based solely on symptoms is insufficient when reliable laboratory confirmation is available. Severe intestinal disease may be complicated by marked mucosal ulceration, significant gastrointestinal bleeding, fulminant colitis, intestinal perforation, or peritonitis. These complications are uncommon but potentially life-threatening and may require intensive supportive care and specialist intervention. In endemic settings, the possibility of invasive amoebiasis should be considered when a patient presents with dysentery and relevant epidemiological exposures, particularly when the illness is persistent or associated with evidence of systemic deterioration. Nevertheless, urgent evaluation must not be delayed while waiting for a single laboratory test if severe colitis or another acute abdominal emergency is suspected. Amoebic liver abscess is the principal extraintestinal manifestation of E. histolytica infection. Patients commonly present with fever, pain or tenderness in the right upper quadrant of the abdomen, malaise, and sometimes hepatomegaly. Gastrointestinal symptoms may be absent, and some patients have no clear history of dysentery. Laboratory findings may include raised inflammatory markers and abnormalities in liver-associated enzymes, but these findings are not specific to amoebic disease. Imaging, particularly ultrasonography or computed tomography when indicated, helps identify the hepatic lesion, while serological testing and the overall clinical picture contribute to determining its likely cause. Stool microscopy may be negative in patients with liver abscess because active intestinal infection is not always detectable at the time of presentation. The differential diagnosis of a hepatic abscess includes pyogenic liver abscess and other focal hepatic lesions. Distinguishing amoebic from bacterial infection is clinically important because management differs. In selected cases, aspiration may be required when the diagnosis is uncertain, bacterial infection is suspected, the lesion is at risk of rupture, or the patient fails to respond to appropriate medical therapy. Pleuropulmonary involvement may occur when a hepatic abscess extends through the diaphragm, whereas cerebral amoebiasis is rare and generally associated with severe disease. Early diagnosis and appropriate management reduce the risk of these complications and improve clinical outcomes. Laboratory Diagnosis and Therapeutic Principles The laboratory diagnosis of amoebiasis requires a combination of clinical assessment, epidemiological information, and appropriately selected diagnostic investigations. Conventional stool microscopy remains widely used because it is relatively inexpensive and accessible in many healthcare facilities. Examination may reveal cysts in formed stool or trophozoites in diarrhoeal specimens. Motile trophozoites containing ingested erythrocytes are strongly suggestive of E. histolytica, but morphological findings must be interpreted carefully, and species-specific confirmation may still be necessary. In addition, a negative result from a single stool specimen does not reliably exclude infection because parasite shedding may vary over time. Examination of multiple specimens collected on separate occasions, together with concentration or staining methods where appropriate, may improve diagnostic yield. Microscopy has important limitations because E. histolytica is morphologically indistinguishable from certain related amoebae, particularly E. dispar, in routine stool preparations. Since E. dispar is generally considered non-invasive, this distinction has direct clinical significance. Detection of amoebic cysts alone therefore should not be interpreted automatically as proof of pathogenic E. histolytica infection. Species-specific stool antigen assays can provide additional diagnostic information, while polymerase chain reaction (PCR) and real-time PCR offer greater specificity for differentiating closely related species when validated assays are available. The choice of method depends on the clinical context, laboratory resources, specimen handling, and the need for rapid or definitive confirmation. Serological testing has a particular role in suspected extraintestinal amoebiasis, especially amoebic liver abscess. Antibodies against E. histolytica are frequently detectable in patients with invasive disease, although interpretation can be more difficult in endemic populations where previous exposure may occur. Imaging is essential for identifying hepatic lesions, but imaging findings alone do not always distinguish amoebic from pyogenic abscesses. Accordingly, the diagnosis of amoebic liver abscess should integrate clinical presentation, epidemiological history, imaging findings, and laboratory evidence. Endoscopy with histopathological examination may be considered in selected patients with persistent or unexplained colitis when initial investigations are inconclusive, provided the procedure is clinically appropriate. The treatment of amoebiasis depends on whether the infection is asymptomatic, confined to the intestinal lumen, or associated with invasive disease. Confirmed asymptomatic E. histolytica infection is generally treated with an appropriate luminal amoebicide to eradicate intestinal infection and reduce the risk of subsequent invasive disease and transmission. Invasive intestinal amoebiasis and amoebic liver abscess generally require a tissue-active agent, such as metronidazole or tinidazole, followed by a luminal agent to eliminate organisms that may remain in the intestinal lumen. Tissue-active therapy alone may not reliably eradicate luminal infection; therefore, completing the appropriate treatment sequence is an important principle of management. The selection of a drug, dose, duration, and route of administration must be based on the patient's clinical condition, age, pregnancy status, comorbidities, contraindications, and current local clinical guidance. Severe colitis or suspected complications require hospital-based assessment and supportive management, including fluid and electrolyte replacement when necessary. Patients with suspected amoebic liver abscess should be assessed for complications and response to treatment, and drainage may be indicated in selected cases rather than being required routinely for every abscess. Treatment decisions should be made by qualified healthcare professionals, and persistent symptoms or failure to improve should prompt reassessment of the diagnosis, adherence, possible complications, and alternative causes of disease. Public Health Implications and Conclusions The prevention of amoebiasis depends primarily on reducing exposure to infective cysts through improvements in sanitation, water safety, food hygiene, and personal hygiene. Reliable drinking-water treatment, protection of water supplies from faecal contamination, appropriate sewage disposal, and safe handling of food are essential components of prevention. Handwashing with soap after using the toilet, after changing diapers, and before preparing or eating food can reduce fecal–oral transmission. Washing produce with safe water and preventing contamination during food preparation are also important, particularly in households and institutions where sanitation facilities are limited. For Iraq, strengthening the epidemiological evidence base should be considered a priority. Future investigations should distinguish confirmed E. histolytica infection from other intestinal amoebae and from the broader category of intestinal parasitic infections. Studies should clearly describe their sampling strategies, population characteristics, diagnostic methods, and denominators so that their findings can be interpreted correctly and compared across governorates. Integrating validated molecular or species-specific antigen assays into selected referral laboratories would improve diagnostic accuracy and support more reliable estimates of the national burden of disease. Collaboration between medical colleges, teaching hospitals, public health laboratories, and environmental health authorities could further strengthen surveillance and help identify areas requiring targeted intervention. Health education should be incorporated into school programmes, community outreach, and clinical practice, with particular attention to safe water consumption, proper sanitation, and early recognition of persistent diarrhoea or dysentery. Healthcare professionals should be trained to interpret stool microscopy cautiously, recognize the limitations of morphological identification, and investigate possible extraintestinal disease when the clinical presentation warrants it. In parallel, improvements in laboratory quality assurance and standardized reporting would enhance the reliability of both clinical diagnosis and epidemiological research. In conclusion, Entamoeba histolytica is an important human pathogen capable of causing asymptomatic intestinal infection, invasive amoebic colitis, and potentially severe extraintestinal disease. Its transmission is closely associated with environmental sanitation and the safety of food and water, while the severity of disease depends on interactions between parasite virulence and host factors. In the Iraqi context, meaningful assessment of the disease burden requires particular attention to the limitations of hospital-based prevalence estimates and the inability of routine microscopy to reliably distinguish pathogenic E. histolytica from morphologically similar species. An integrated strategy combining accurate diagnosis, appropriate treatment, improved sanitation, health education, and standardized epidemiological surveillance offers the most effective foundation for reducing the clinical and public health impact of amoebiasis.